MSCT联合螺旋CT增强扫描在肝脏肿瘤类型中的鉴别价值分析

摘要/Abstract

摘要： 目的探讨与分析多层螺旋CT（multislice computer tomography,MSCT）联合螺旋CT增强扫描在体检患者鉴别肝脏肿瘤类型中的价值。方法选择2016年9月~2018年12月在32261部队放射科诊治的肝脏肿瘤80例作为研究对象,所有患者都给予MSCT联合螺旋CT增强扫描,记录影像学特征并通过与病理诊断的对比判断诊断价值。结果在80例患者中,病理诊断为肝脏良性肿瘤43例（良性肿瘤组）,肝脏恶性肿瘤37例（恶性肿瘤组）。恶性肿瘤组的CT图像显示肿瘤出血、坏死囊变、钙化占比分别为56.76%、59.46%、64.86%,明显高于良性肿瘤组的13.95%、9.30%、11.62%（P<0.05）。恶性肿瘤组的CT增强扫描动脉期、门脉期、平衡期的CT值明显高于良性肿瘤组（P<0.05）。恶性肿瘤组的CT增强方式多为不均匀强化（n=32）,良性肿瘤组多为均匀强化（n=40）,对比差异有统计学意义（P<0.05）。MSCT联合螺旋CT增强扫描判断为肝脏良性肿瘤42例,肝脏恶性肿瘤38例,MSCT联合螺旋CT增强扫描判鉴别诊断肝脏肿瘤良恶性的敏感度与特异度分别为97.67%和100.00%,受试者工作特征（receiver operating characteristic,ROC）曲线显示MSCT联合螺旋CT增强预测肝脏良恶性肿瘤的最大曲线下面积为0.719。结论肝脏良恶性肿瘤的形态特征、强化特征、CT值均可作为鉴别参数,MSCT联合螺旋CT增强扫描判鉴别诊断肝脏肿瘤良恶性具有重要的意义,具有临床应用价值。

关键词: 多层螺旋CT, CT增强扫描, 肝脏肿瘤, 良恶性, 诊断价值, 敏感度, 特异度

Abstract: Objective To explore and analysis the values of multislice computer tomography (MSCT) combined with enhanced helical CT scan in differentiating liver tumor types in physical examination patients. Methods From September 2016 to December 2018, a total of 80 cases of liver tumors diagnosed and treated in 32261 Army Radiology Department were selected as the research subjects. All patients were given MSCT combined with helical CT enhanced scanning, and the imaging features were recorded and the diagnostic value were judged. Results In the 80 patients, 43 cases were pathologically diagnosed as benign liver tumors (benign tumor group), and 37 cases were malignant liver tumors (malignant tumor group). The proportion of CT tumor hemorrhage, necrosis and cystic degeneration and calcification in the malignant tumor group(56.76%,59.46%,64.86%)were significantly higher than that in the benign tumor group(13.95%,9.30%,11.62%) (P<0.05). The CT value of the CT enhanced scan in the malignant tumor groupof arterial phase, portal phase, equilibrium phase were significantly higher than that in the benign tumor group (P<0.05). The CT enhancement mode of malignant tumor group were mostly heterogeneous enhancement(n=32), while benign tumor groupwere mostly homogeneous enhancement(n=40), and there were significant difference in contrast (P<0.05). MSCT combined with helical CT enhanced scanning were judged to be 42 cases of benign liver tumors and 38 cases of liver malignant tumors. The sensitivity and specificity of MSCT combined with helical CT enhanced scanning for differential diagnosis of benign and malignant liver tumors were 97.67% and 100.00%. The receiver operating characteristic (ROC) curve showed that the maximum area under the curve of MSCT combined with helical CT enhancement for predicting benign and malignant liver tumors was 0.719. Conclusion Morphological features, enhancement features, and CT values of benign and malignant liver tumors can be used as differential parameters. MSCT combined with helical CT enhanced scanning has important significance in the differential diagnosis of benign and malignant liver tumors, and has clinical application value.

Key words: multislice spiral CT, enhanced CT scan, liver tumor, benign and malignant, diagnostic value, sensitivity, specificity

中图分类号:

R445

冉华, 曾宪光, 荣宏广, 樊文秀. MSCT联合螺旋CT增强扫描在肝脏肿瘤类型中的鉴别价值分析[J]. 中华养生保健, 2022, 40(12): 23-27.

RAN Hua, ZENG Xian-guang, RONG Hong-guang, FAN Wen-xiu. Analysis of the Differential Value of MSCT Combined with Helical CT Enhanced Scanning in Liver Tumor Types[J]. ZHONGHUA YANGSHENG BAOJIAN, 2022, 40(12): 23-27.

参考文献

[1] 游家生,吕秀金,郭伟娟.动态增强MRI与CT对乙型肝炎肝硬化背景下原发性肝癌的诊断价值[J].海南医学,2022,33(1):79-82.
[2] Refaat R, Basha M A A, Hassan M S, et al.Efficacy of contrast-enhanced FDG PET/CT in patients awaiting liver transplantation with rising alpha-fetoprotein after bridge therapy of hepatocellular carcinoma[J].Eur Radiol,2018,28(12):5356-5367.
[3] 季学闻,马利兵.1.5T MR多序列检查在小肝癌诊断中的应用[J].中国CT和MRI杂志,2022,2(2):87-89.
[4] 李昱茜,孟欣,白炜,等.超声造影与增强MSCT对腹部占位性病灶诊断效能对比[J].中国CT和MRI杂志,2022,2(2):146-148.
[5] 刘新爱,任月勤.应用DCE-MSCT扫描鉴别诊断小肝癌及肝硬化再生结节的可行性研究[J].中国CT和MRI杂志,2022,20(3):77-79.
[6] 马静,张雅静,刘永欣.MSCT对小儿常见肝脏良、恶性肿瘤鉴别诊断价值分析[J].中国CT和MRI杂志,2022,2(2):90-92.
[7] 崔玉芝,时高峰,刘欢,等.关于钆塞酸二钠及钆喷酸葡胺增强MRI对肝癌诊断效能的1∶1匹配的病例对照研究[J].临床放射学杂志,2022,41(1):81-85.
[8] 柯利, 韦福康. 肝脏肿瘤[M].北京:人民卫生出版社, 2001:98-99.
[9] 骆秋霞,李远辉,张建生,等.双层探测器光谱CT低keV虚拟单能级图像在小肝癌评估中的应用[J].中华肝脏外科手术学电子杂志,2021,10(5):489-492.
[10] 祝令武. 增强CT纹理参数评估肝细胞肝癌患者新辅助化疗预后的价值[J].河南医学研究,2021,30(32):6088-6091.
[11] 曹青峰. 螺旋CT灌注成像与超声造影在肝癌介入疗效及术后肿瘤活性评估中的应用[J].中国CT和MRI杂志,2021,19(2):94-95,117.
[12] 杨建,陈小军,张建.MSCT三期增强扫描对肝占位性病变性质的诊断及临床价值研究[J].中国CT和MRI杂志,2021,19(10):112-114.
[13] 陶景山,臧晓进,戴益盛,等.肝癌脑转移瘤合并卒中患者CT、核磁共振影像学特点及预后因素分析[J].中西医结合肝病杂志,2021,31(3):271-273.
[14] 王翠祥,秦新华,刘铜锁.能谱CT定量分析对原发性肝癌及肝脓肿患者的鉴别诊断效果研究[J].医药论坛杂志,2021,42(13):48-50.
[15] Gulpinar B, Peker E, Soydal C, et al.Can we differentiate histologic subtypes of neuroendocrine tumour liver metastases at a single phase contrast-enhanced CT-correlation with Ga-68 DOTATATE PET/CT findings[J].Br J Radiol,2020,93(1106):20190735.
[16] 彭光明,葛尚,井桂银.自适应性统计迭代重建联合低管电压提高肝细胞癌患者肝脏CT三期增强扫描图像质量研究[J].实用肝脏病杂志,2021,24(5):737-740.
[17] 孙德生,徐宏伟,徐惠亮,等.中晚期原发性肝癌TACE术后疗效评价标准的比较[J].浙江临床医学,2021,23(12):1709-1711.
[18] 项改生,姜增誉,陈文青,等.能谱CT在肝脏疾病中的研究新进展[J].中国CT和MRI杂志,2021,19(7):178-180.
[19] 吴水天. CT增强扫描在评估原发性肝细胞肝癌TACE术后疗效中的应用[J].中国CT和MRI杂志,2022,20(3):91-93.
[20] 袁丹丹, 刘静, 曹笑婉, 等. 肝脏原发性神经内分泌肿瘤三期增强扫描CT特征[J]. 临床放射学杂志, 2020(12):39(12): 2462-2465.